aspirin 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [Ascomp]
RxNorm concept 994239, branded drug (sbd). Prescribable name: Ascomp with Codeine 50 MG / 325 MG / 40 MG / 30 MG Oral Capsule.
- RxCUI
- 994239
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/994239 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
ASA 325 MG / butalbital 50 MG / Caffeine 40 MG / Codeine Phosphate 30 MG Oral Capsule [Ascomp]; Ascomp with Codeine (ASA 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG) Oral Capsule
Related concepts
- aspirin 325 MG (SCDC, consists of)
- butalbital 50 MG (SCDC, consists of)
- caffeine 40 MG (SCDC, consists of)
- codeine phosphate 30 MG (SCDC, consists of)
- aspirin 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG [Ascomp] (SBDC, consists of)
- Oral Capsule (DF, has dose form)
- Ascomp (BN, has ingredient)
- aspirin 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 994239 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/994239 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 994239. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.